Home

Press Releases

12345678910
Gat Sport Partners With 24 Hour Fitness to Launch Nitraflex Ultra
GAT Sport(R) Launches NITRAFLEX(R) ULTRA Through 24 Hour Fitness Locations Nationwide.
Via ACCESS Newswire · May 19, 2025
Spring Surge in Edmonton Housing: Mortgage Broker Shares Expert Tips for First-Time Buyers
Navigating a hot market: Local mortgage expert offers essential guidance to help new buyers succeed this spring
Via ACCESS Newswire · May 19, 2025
Porsche Cars North America’s Ayesha Coker recognized among 100 leading women in the North American auto industry
Coker has led Marketing for the sport car maker’s largest market since 2022
Aspira Announces First Quarter 2025 Financial Results and Provides Business Update
AUSTIN, TX / ACCESS Newswire / May 19, 2025 / Aspira Women's Health Inc. ("Aspira") (OTCQB:AWHL), an AI enhanced bio-analytics based women's health company focused on delivering leading noninvasive gynecologic disease diagnostic and disease management tools, announced today its results of operations for the three-month period ended March 31, 2025. The Company also reported early progress under its new leadership team. Key financial highlights for the quarter are summarized below:
Via ACCESS Newswire · May 19, 2025
Market Alert: DarioHealth Receives $3 Price Target and Buy Rating: Everything You Need to Know
Analyst Buy Rating for NASDAQ: DRIO* Driven by 398% Revenue Growth, AI Cost-Cutting Initiatives, and Promising GLP-1 Program Results
Via News Direct · May 19, 2025
Phio Pharmaceuticals Announces Participation in the Sidoti Micro-Cap Virtual Investor Conference
Marlborough, Massachusetts--(Newsfile Corp. - May 19, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing...
Via Newsfile · May 19, 2025
Juniper Networks and ServiceNow Extend Partnership with Combined Solution to Accelerate Time-to-Value for Deutsche Telekom Managed Services with End-to-End Automation
Juniper Networks (NYSE: JNPR), a leader in secure, AI-native networks, extends its partnership with ServiceNow to integrate Juniper’s AI-native networking platform, Mist™, with ServiceNow Telecom Service Management, Inventory and Sales & Order Management for Telecom. The combined solution brings end-to-end network and service automation together with AI-native, cloud-native and 100 percent API-driven wired, wireless and SD-WAN solutions to drive business transformation and deliver unparalleled efficiencies and cost savings to enterprises and MSPs. This integration is the first of its kind for the solution.
By Juniper Networks · Via Business Wire · May 19, 2025
Indonesia Elevator and Escalator Market Size & Growth Forecast Report 2025-2030 Featuring Top Manufacturers - Schindler, TK Elevators, Otis, KONE, and Mitsubishi Electric - ResearchAndMarkets.com
The "Indonesia Elevator and Escalator Market Size & Growth Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · May 19, 2025
Protagenic Therapeutics and Phytanix Announce Business Combination to form Neuroactive Biopharmaceutical Company with Six Drug Candidates in Development including Treatments for Obesity and Metabolic Disorders
NEW YORK, NY AND SANTA BARBARA, CA / ACCESS Newswire / May 19, 2025 / Protagenic Therapeutics, Inc. (Nasdaq:PTIX) (the "Company") and Phytanix Bio Inc. have entered into a definitive share exchange agreement pursuant to which the two entities will combine in an all-stock transaction (the "Combination"). The combined entity, to be called Phytanix, Inc., will bring together two pipelines focused on stress-related and CNS disorders, five preclinical assets and one clinical-stage asset.
Via ACCESS Newswire · May 19, 2025
Risk-based Computer System Validation: Reduce Costs and Avoid 483s - 2 Day Online Course (August 6-7, 2025) - ResearchAndMarkets.com
The "Risk-based Computer System Validation; Reduce Costs and Avoid 483s (ONLINE EVENT: August 6-7, 2025)" has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · May 19, 2025
DocGo Wins “Compliance Management Innovation Award” in 2025 MedTech Breakthrough Awards Program
DocGo Inc. (Nasdaq: DCGO) (“DocGo”), a leading provider of technology-enabled mobile health services, today announced that it has been selected as winner of the “Compliance Management Innovation Award” in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market.
By DocGo Inc. · Via Business Wire · May 19, 2025
AMD Announces Agreement to Divest ZT Systems Data Center Infrastructure Manufacturing Business to Sanmina
SANTA CLARA, Calif., May 19, 2025 (GLOBE NEWSWIRE) -- AMD (NASDAQ: AMD) today announced it has entered into a definitive agreement to sell ZT Systems’ U.S.-headquartered data center infrastructure manufacturing business to Sanmina (NASDAQ: SANM), a leading integrated manufacturing solutions company. As part of the transaction, Sanmina becomes a preferred new product introduction (NPI) manufacturing partner for AMD cloud rack and cluster-scale AI solutions. AMD will retain ZT Systems’ world-class design and customer enablement teams to accelerate the quality and time-to-deployment of AMD AI systems for cloud customers.
Vonlane to Offer New Daily Non-Stop Service Between Nashville and Knoxville, Beginning June 13th
Vonlane, the premium regional transportation company, will offer daily luxury motor coach service between Nashville and Knoxville starting on June 13. The coach will depart Nashville at 10 a.m. from the Omni Nashville Hotel, located downtown, and Knoxville at 3 p.m. from The Tennessean Hotel, located downtown and one mile from Neyland Stadium. Fares are a flat rate of $125 for one-way trips with advance purchase.
By Vonlane · Via Business Wire · May 19, 2025
Renowned IO Economist Professor B. Douglas Bernheim Affiliates with Compass Lexecon
WASHINGTON, May 19, 2025 (GLOBE NEWSWIRE) --  FTI Consulting, Inc. (NYSE: FCN) today announced that B. Douglas Bernheim, the Edward Ames Edmonds Professor of Economics at Stanford University, has affiliated with its subsidiary Compass Lexecon.
By FTI Consulting, Inc. · Via GlobeNewswire · May 19, 2025
PENN Entertainment Sends Letter to Shareholders
PENN Entertainment, Inc. (Nasdaq: PENN) (“PENN” or the “Company”) today issued the following letter to shareholders.
By PENN Entertainment, Inc. · Via Business Wire · May 19, 2025
Camping World Appoints Brent Moody as Vice Chairman
Camping World Holdings, Inc. (NYSE: CWH) (“Camping World”), the World’s Largest Recreational Vehicle Dealer, announced that the Board of Directors (the “Board”) has appointed Brent Moody as Vice Chairman, effective May 15, 2025. As Vice Chairman, Mr. Moody will work closely with the executive team and the Board to support long-term value creation.
By Camping World · Via Business Wire · May 19, 2025
Western Global Airlines Inaugurates New Base Maintenance Operation in Blytheville, Arkansas
Western Global Airlines, Inc., the “can-do airline,” announced today that it had opened a new base maintenance facility at Arkansas International Airport in Blytheville, Arkansas. The new facility includes a 50,000 ft2 hangar, 40,000 ft2 of stores capacity, and is adjacent to a premier suite of aviation component repair, sheet metal, and machine shops. Maintenance operations for WGA at the site are expected to commence in June 2025.
The Arab Energy Fund and Stonepeak Enter $1 Billion Strategic Partnership to Advance Energy Infrastructure Across the Middle East
The Arab Energy Fund (formerly APICORP), a leading multilateral impact financial institution focused on the MENA energy sector, and Stonepeak, the world’s largest independent infrastructure firm and leading US infrastructure investor, today announced that they have entered into a strategic partnership to invest in energy infrastructure across the Middle East.
By Stonepeak · Via Business Wire · May 19, 2025
Quantum Biopharma Purchases an Additional USD $1 Million of Bitcoin and Other Cryptocurrencies to Hold BTC Treasury and To Generate Staking Revenue. Bringing the Total Investment in Digital Assets to USD $4,500,000
TORONTO, May 19, 2025 (GLOBE NEWSWIRE) -- Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce that after receiving approval from the Board of Directors, the Company has purchased an additional USD $1,000,000 worth of Bitcoin (BTC) and other cryptocurrencies as part of its strategic efforts. This brings the total amount of BTC and other cryptocurrencies purchased to USD $4,500,000. As previously announced the company will continue to allow for future financing and other transactions to be carried out in cryptocurrency.
By Quantum BioPharma · Via GlobeNewswire · May 19, 2025
Reunion Neuroscience Announces Last Patient Dosed in RECONNECT Phase 2 Clinical Trial of RE104 for the Treatment of Postpartum Depression (PPD)
-- Enrollment Completed on Schedule; Topline Results Expected Q3 2025 --
By Reunion Neuroscience Inc. · Via GlobeNewswire · May 19, 2025
Atsena Therapeutics Announces Positive Clinical Data from Part A of Phase I/II Trial Evaluating ATSN-201 Gene Therapy to Treat X-linked Retinoschisis (XLRS)
First XLRS study to demonstrate efficacy and positive safety data in a Phase I/II trial
By Atsena Therapeutics · Via GlobeNewswire · May 19, 2025
Data Center Colocation Market Analysis and Forecast, 2025-2034 | Data Center Colocation Market to Surge at 14.65% CAGR, Reaching $569.58 Billion by 2034 - ResearchAndMarkets.com
The "Data Center Colocation Market - A Global and Regional Analysis: Focus on Application, Product, and Region - Analysis and Forecast, 2025-2034" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · May 19, 2025
Fluor-Built Pharmaceutical Facility in California is First Industrial Manufacturing Facility in Western United States to Achieve LEED v4 Platinum Certification
Fluor Corporation (NYSE: FLR) announced today that Bayer’s Cell Therapy Launch Facility in Berkeley, California, has been designated the first industrial manufacturing facility in the Western United States to achieve Leadership in Energy and Environmental Design (LEED) v4 Platinum Certification. The project was also named the 2025 Facility of the Year for Social Impact - Unmet Medical Needs by the International Society for Pharmaceutical Engineering (ISPE).
By Fluor Corporation · Via Business Wire · May 19, 2025
United States Electric Vehicle and Charging Infrastructure Market: Investment Opportunities and Future Outlook Databook 2025-2029 - ResearchAndMarkets.com
The "United States Electric Vehicle and Charging Infrastructure Market: Investment Opportunities and Future Outlook Databook - 50+ KPIs Covering EV Market Size by Value and Volume, Vehicle Type, Price Point, Propulsion Type, Location - Q2 2025 Update" report has been added to ResearchAndMarkets.com's offering.
By Research and Markets · Via Business Wire · May 19, 2025
Gradient Denervation Technologies Announces FDA Breakthrough Designation for Pulmonary Artery Denervation System
PARIS, May 19, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). This program creates an expedited review pathway for devices that have the potential to provide more effective treatment for life-threatening or debilitating conditions and meet FDA’s rigorous standards for safety and efficacy.
MultiBank Group Named Best Global ECN Broker at Forex Traders Summit 2025
MultiBank Group, one of the world’s largest financial derivatives institutions headquartered in Dubai, has been awarded the prestigious title of ‘Best Global ECN Broker’ during the Forex Traders Summit 2025, held from May 14–15 at the Festival Arena in Dubai.
By MultiBank Group · Via Business Wire · May 19, 2025
Regeneron Enters into Asset Purchase Agreement to Acquire 23andMe® for $256 Million; Plans to Maintain Consumer Genetics Business and Advance Shared Goals of Improving Human Health and Wellness
Purchase is subject to bankruptcy court and regulatory approvals
Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale
Regeneron Commits to Comply with Company’s Privacy Policy and All Applicable Law; No Changes to 23andMe’s Privacy Policy or Consumer Genome Services
By 23andMe, Inc. · Via GlobeNewswire · May 19, 2025
Global Cities Named for Breaking Down Health Data Barriers and Leading EHR Connectivity in 2025 - Black Book Research
New international rankings spotlight 30 urban health hubs across 57 countries eliminating medical data silos, optimizing electronic records, and setting the pace for cross-sector interoperability
Via ACCESS Newswire · May 19, 2025
Home Care Assistance of Barrie Wins 2025 Consumer Choice Award for Home Healthcare Services
BARRIE, ON / ACCESS Newswire / May 19, 2025 / Consumer Choice Award (CCA) is proud to announce that Home Care Assistance of Barrie has been named the 2025 Consumer Choice Award Winner in the Home Healthcare Services category. This recognition honours the organization's dedication to personalized, compassionate care and its continued commitment to supporting families and their loved ones across the region.
Via ACCESS Newswire · May 19, 2025
Announcing the 2025 Montreal and Regions Consumer Choice Award Winners
MONTREAL, QC / ACCESS Newswire / May 19, 2025 / Consumer Choice Award is pleased to announce the 2025 award recipients in Montreal and surrounding regions. These businesses have been meticulously selected through independent market research, reflecting their commitment to excellence and unparalleled service in their city. Consumer Choice Award celebrates those who have consistently set the benchmark for quality and customer satisfaction. Congratulations to the 2025 Montreal and Regions Consumer Choice Award Winners.
Via ACCESS Newswire · May 19, 2025
Dart Appraisal Appoints Michael Dresden CEO
TROY, MICHIGAN / ACCESS Newswire / May 19, 2025 / Dart Appraisal, a nationwide independent appraisal management company (AMC), has officially appointed Michael Dresden as its new Chief Executive Officer. He is only the second individual to occupy this role in the company's 32-year history. In his new position, Michael will oversee all company operations and spearhead ambitious growth initiatives.
Via ACCESS Newswire · May 19, 2025
Reviews Are In: Tony Robbins & Dean Graziosi Launch All-In-One Mastermind Business System to Help People Create A Thriving Business In a Changing World
The Mastermind Business System removes the #1 barrier for aspiring entrepreneurs-by combining AI mentorship, training, and all-in-one tools in one platform.
Via ACCESS Newswire · May 19, 2025
Phillips 66 Issues Letter to Shareholders
Phillips 66 (NYSE:PSX) today sent a letter to shareholders highlighting the key issues on the ballot at its Annual Meeting on May 21.
By Phillips 66 · Via Business Wire · May 19, 2025
Amerit Fleet Solutions Appoints Chris Moulden as Senior Vice President of Safety
Amerit Fleet Solutions (“Amerit”), a leading provider of customized fleet maintenance and repair programs nationwide, today announced the appointment of Chris Moulden as Senior Vice President of Safety. With more than two decades of experience shaping national safety standards, Mr. Moulden will lead the execution and continuous improvement of Amerit’s safety strategies across all operations nationwide.
By Amerit Fleet Solutions · Via Business Wire · May 19, 2025
Ethical Energy Solar Partners with Penn State Athletics to Promote Energy Independence
York, Pennsylvania--(Newsfile Corp. - May 19, 2025) - Ethical Energy Solar, a Pennsylvania solar energy provider, is pleased to announce...
Via Newsfile · May 19, 2025
Ionis announces positive topline results from Essence study of olezarsen in people with moderately elevated triglycerides
Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today announced positive topline results from the Essence study of olezarsen in people with moderate hypertriglyceridemia (fasting triglycerides ≥150 mg/dL to <500 mg/dL) with or at risk for atherosclerotic cardiovascular disease (ASCVD). Nearly all the participants were on current standard of care lipid-lowering medicines. The trial met its primary endpoint with a statistically significant placebo-adjusted 61% and 58% reduction in triglyceride (TG) levels at 6 months with the 80 mg and 50 mg monthly doses, respectively (p <0.0001). Olezarsen also met all key secondary endpoints in the study. The vast majority of participants reached <150mg/dL, reflecting a reduction to normal TG levels. Olezarsen demonstrated a favorable safety and tolerability profile in the study. Ionis plans to submit an abstract for presentation at an upcoming scientific conference. Data from the pivotal Phase 3 CORE and CORE2 studies evaluating olezarsen for the treatment of severe hypertriglyceridemia (sHTG) are expected in Q3 2025.
By Ionis Pharmaceuticals, Inc. · Via Business Wire · May 19, 2025
Aeva Selected by World's Largest Commercial Aircraft Manufacturer
Aeva® (Nasdaq: AEVA), a leader in next-generation sensing and perception systems, today announced that it has been selected by Airbus UpNext, a wholly-owned Airbus subsidiary created to explore innovative technologies, to supply its cutting-edge 4D LiDAR technology for the Optimate smart automation demonstrator.
By Aeva Technologies, Inc. · Via Business Wire · May 19, 2025
F5 Expands Strategic Collaboration with Red Hat to Enable Scalable, Secure Enterprise AI
F5 (NASDAQ: FFIV), the global leader in delivering and securing every app and API, today announced an expanded collaboration with Red Hat, the world’s leading provider of open source solutions, to help enterprises deploy and scale secure, high-performance AI applications. By enabling integration for the F5 Application Delivery and Security Platform with Red Hat OpenShift AI, F5 customers can adopt AI faster and more securely, focusing on practical, high-value use cases such as retrieval-augmented generation (RAG), secure model serving, and scalable data ingestion.
By F5, Inc. · Via Business Wire · May 19, 2025
F5 Delivers Scalable and Secure Cloud-Native Network Functionality for AI and High-Bandwidth Applications
F5 (NASDAQ: FFIV), the global leader in delivering and securing every app and API, today unveiled F5 BIG-IP Next Cloud-Native Network Functions (CNF) 2.0, an evolved solution that significantly enhances the capabilities of the F5 Application Delivery and Security Platform (ADSP) for large-scale cloud-native applications. With advanced Kubernetes-native features, F5 BIG-IP Next CNF 2.0 redefines how organizations adapt to increasingly complex and resource-intensive operations caused by high-bandwidth applications such as AI by delivering scalable, resource-efficient, and secure network functionality for telecommunications service providers, internet service providers (ISPs), cloud service providers, and large enterprises.
By F5, Inc. · Via Business Wire · May 19, 2025
Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to ZL-1310, the Company’s potential first-in-class Delta-like ligand (DLL3) antibody-drug conjugate (ADC), for the treatment of extensive-stage small cell lung cancer (ES-SCLC). ZL-1310, which is being evaluated in an ongoing global Phase 1a/1b clinical trial (NCT06179069), previously received an Orphan Drug designation for SCLC from the FDA. The company will present updated data at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting.
By Zai Lab Limited · Via Business Wire · May 19, 2025
Fifth Third Becomes First Bank to Offer Free Wills to All Customers
Fifth Third (NASDAQ: FITB) today announced a first-of-its-kind initiative to offer free wills to every customer, through an exclusive partnership with Trust & Will, the leading digital estate planning platform in the U.S.
By Fifth Third · Via Business Wire · May 19, 2025
$TRUMP Token is Now a True Currency on the PDX Beam Payments Platform
PDX Global, a digital payments technology developer for the crypto economy, today announced that PDX Beam—its proprietary crypto-to-cash payments platform for consumers and merchants—now hosts and supports OFFICIAL TRUMP, the $TRUMP token. It is one of the crypto tokens on the Beam platform that can be used for merchant payments and is instantly convertible to cash.
By PDX Global · Via Business Wire · May 19, 2025
BreachRx Closes $15M Series A Funding to End the Chaos of Cybersecurity Incident Response
BreachRx, provider of the first intelligent incident response platform designed for the entire enterprise, today announced the closing of an oversubscribed $15 million Series A funding round led by Ballistic Ventures, with participation from SYN Ventures, Overline, and Silver Buckshot Ventures. The company also announced the appointments of Ballistic Ventures General Partner and former Mandiant CEO Kevin Mandia to the Board of Directors, and best-selling author and former New York Times lead cybersecurity reporter Nicole Perlroth as Board Observer. The investment brings the company’s total funding raised to over $23 million.
By BreachRx · Via Business Wire · May 19, 2025
IDeate-Esophageal01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Certain Patients with Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma
The first patient has been dosed in the IDeate-Esophageal01 phase 3 trial evaluating the efficacy and safety of investigational ifinatamab deruxtecan (I-DXd) versus investigator’s choice of chemotherapy in patients with unresectable advanced or metastatic esophageal squamous cell carcinoma (ESCC) with disease progression following treatment with a platinum-containing systemic therapy and an immune checkpoint inhibitor.
By Daiichi Sankyo · Via Business Wire · May 19, 2025
Infinium will deploy Electric Hydrogen’s electrolyzer plant at large-scale eFuels facility in Texas
PECOS, Texas, May 19, 2025 (GLOBE NEWSWIRE) -- Electric Hydrogen, an American manufacturer of high-power electrolyzer plants, announced today that Infinium, a leading producer of commercial eFuels, has selected Electric Hydrogen’s 100 megawatt (MW) HYPRPlant for its large-scale eFuels facility in Texas, Project Roadrunner.
By Electric Hydrogen · Via GlobeNewswire · May 19, 2025
Mobilicom Provides First Quarter 2025 Update and Financial Highlights
Continued momentum in sales to Tier-1 defense manufacturers gearing up for program of record deliveries for end users including the U.S. Department of Defense (DoD) and other major world militaries
By Mobilicom Limited · Via GlobeNewswire · May 19, 2025
LanzaTech Announces First Quarter 2025 Financial Results
CHICAGO, May 19, 2025 (GLOBE NEWSWIRE) -- LanzaTech Global, Inc. (NASDAQ: LNZA) (“LanzaTech” or the “Company”), a carbon management solutions company, today reported its financial and operating results for the first quarter of 2025.
By LanzaTech Inc. · Via GlobeNewswire · May 19, 2025
Mesa Air Group Reports First Quarter Fiscal 2025 Results
PHOENIX, May 19, 2025 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today reported first quarter fiscal 2025 financial and operating results.
By Mesa Air Group, Inc. · Via GlobeNewswire · May 19, 2025
OKYO Pharma to Present at the GPCRs-Targeted Drug Discovery Summit
LONDON and NEW YORK, May 19, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain, a severe ocular condition without an FDA approved therapy, and for inflammatory eye diseases, announced that its CEO, Gary S. Jacob, Ph.D., will be giving an oral presentation at the 4th Annual GPCRs-Targeted Drug Discovery Summit in Boston, MA on May 22, 2025. Dr. Jacob’s presentation will cover the development of urcosimod, OKYO’s lead clinical drug candidate, to treat neuropathic corneal pain (NCP) which is a debilitating condition affecting many tens of thousands worldwide, and is characterized by chronic, severe eye discomfort.
By OKYO Pharma LTD · Via GlobeNewswire · May 19, 2025